<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871868</url>
  </required_header>
  <id_info>
    <org_study_id>2018/11/43</org_study_id>
    <nct_id>NCT03871868</nct_id>
  </id_info>
  <brief_title>Vitamin D Levels And Myoma Uteri</brief_title>
  <official_title>Vitamin D Levels İn Women With and Without Myoma Uteri</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women with at least one uterine leiomyoma and polycystic ovary syndrome over 10 mm and women
      with normal ultrasonographic findings were included in the study. Blood samples were taken
      for biochemical analysis such as vitamin D, calcium, magnesium, phosphorus, thyroid
      stimulating hormone (TSH), hemoglobin (hb), hematocrit (htc), platelet (plt), and albumin.
      The study groups were compared in terms of these biochemical markers and family history of
      patients, daily sunshine hours, clothing preferences and education level.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>december 2018- march 2019</time_frame>
    <description>Vitamin D levels in blood test</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Myoma;Uterus</condition>
  <condition>Vitamin D Deficiency</condition>
  <condition>Polycystic Ovary</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>In Woman With Myoma Uteri</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>In Woman Without Myoma Uteri</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The reproductive age women (25-50 years) with at least one 10 mm or larger diameter
        leiomyoma detected by transvaginal ultrasound were the study group.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: The reproductive age women (25-50 years) with at least one 10 mm or
        larger diameter leiomyoma detected by transvaginal ultrasound were the study group.

        Exclusion Criteria:

          -  Patients with a history of myomectomy,

          -  chronic systemic disease

          -  malignancy

          -  history of adenomyosis

          -  women in menopause

          -  pregnant women

          -  vitamin D supplementation

          -  lactation

          -  abortion and pregnancy loss in the last 6 months

          -  oral contraceptive / hormonal agents in the last 3 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>25-50 years old women with and without myoma uteri</gender_description>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Kanuni Sultan Süleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>33403</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Kadirogulları</investigator_full_name>
    <investigator_title>pınar kadiroğulları M.D, Department of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>25-hydroxyvitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myoma</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

